fig1
From: Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience
Figure 1. Trend of biochemical parameters in treated patients with endolymphatic immunotherapy according with number of therapy cycles. Patients who completed 12 therapy cycles (red color) vs. patients with less than 6 cycles (blue colour)
